Unknown NA INTERVENTIONAL 3-arm NCT01891292

Efficacy of Antioxidant Therapy Compared With Enalapril in Sickle Nephropathy

A Phase 2 Study of the Efficacy of Antioxidant Therapy Compared With Enalapril in Slowing the Progression of Sickle Nephropathy in Children

Sponsor: Caribbean Health Research Council

Conditions Microalbuminuria Sickle Cell Nephropathy

Interventions Enalapril N-Acetylcysteine

Updated 5 times since 2017 Last updated: Jun 27, 2013 Started: Jul 31, 2013 Primary completion: Aug 31, 2014 Completion: Sep 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01891292, this NA trial focuses on Microalbuminuria and Sickle Cell Nephropathy and remains ongoing. Sponsored by Caribbean Health Research Council, it has been updated 5 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Jul 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Caribbean Health Research Council
The University of The West Indies

Data source: The University of The West Indies

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kingston, Jamaica